At Baxter, we understand that our treatments are an important decision for a lifetime and that is why we are dedicated to meeting and exceeding industry standard practices to provide effective therapies. BioTherapeutics supports our patients, families, and physicians who have conditions including primary immunodeficiencies, and secondary immunodeficiencies (CLL and myeloma), and ITP. In addition, we support patients and families that require critical care in the areas of plasma-volume replacement therapy for the treatment of hypovolemia and patients with severe congenital Protein C deficiency. In addition the website also includes links to support groups and associations dedicated to PIDs, and educational links to help enhance your knowledge.